Figure 1.
Timeline of US Food and Drug Administration approval of blinatumomab. Ph-, Philadelphia chromosome negative.

Timeline of US Food and Drug Administration approval of blinatumomab. Ph-, Philadelphia chromosome negative.

or Create an Account

Close Modal
Close Modal